Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition) ›› 2016, Vol. 02 ›› Issue (04): 263-265. doi: 10.3877/cma.j.issn.2096-1537.2016.04.008

Special Issue: Critical care medicine

• Opinion • Previous Articles     Next Articles

To treat acute respiratory distress syndrome: I prefer high-flow nasal cannula oxygen therapy

Ling Liu1,()   

  1. 1. Department of Critical Care Medicine, Zhongda Hospital, Southeast University, Nanjing 210009, China
  • Received:2016-10-27 Online:2016-11-28 Published:2016-11-28
  • Contact: Ling Liu
  • About author:
    Corresponding author: Liu Ling, Email:

Abstract:

Acute respiratory distress syndrome (ARDS) is the most common cause of acute hypoxemic respiratory failure. Refractory hypoxemia due to intra-pulmonary shunt is the most prominent clinical manifestation of ARDS. With the therapeutic advantages of increasing positive end expiratory pressure, end-expiratory lung volume and patient comfort, high-flow nasal cannula oxygen therapy (HFNC) has been widely applied as the first-line oxygen therapy strategy in mild and moderate ARDS patients.

Key words: High-flow nasal cannula, Acute respiratory distress syndrome, Positive end expiratory pressure, Oxygen therapy

京ICP 备07035254号-19
Copyright © Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), All Rights Reserved.
Tel: 010-51322627 E-mail: ccm@cma.org.cn
Powered by Beijing Magtech Co. Ltd